nigericin has been researched along with Osteosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, L; Deng, Z; Fang, J; Lv, M; Xie, J; Xie, Y; Yang, M; Yang, Z | 1 |
| Ofori-Darko, E; Tashjian, AH | 1 |
2 other study(ies) available for nigericin and Osteosarcoma
| Article | Year |
|---|---|
Nigericin exerts anticancer effects through inhibition of the SRC/STAT3/BCL-2 in osteosarcoma.
Topics: Animals; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Mice; Nigericin; Osteosarcoma; Proto-Oncogene Proteins c-bcl-2; STAT3 Transcription Factor | 2022 |
Regulation of pHi in Saos-2 cells by thrombin: roles of proteolytic activity and cytosolic calcium transients.
Topics: Alkalies; Calcium; Cytosol; Hirudins; Humans; Hydrogen-Ion Concentration; Nigericin; Osteoblasts; Osteosarcoma; Peptide Hydrolases; Rest; Thrombin; Tumor Cells, Cultured | 1992 |